国际医药卫生导报2024,Vol.30Issue(15) :2465-2469.DOI:10.3760/cma.j.issn.1007-1245.2024.15.001

乳腺浸润性微乳头状癌的多组学研究进展

Overview of multi-omics research on invasive micropapillary carcinoma in breast

闫晨名 蔡艺威 程立浩 范晓瑞 贾中明 王晓红
国际医药卫生导报2024,Vol.30Issue(15) :2465-2469.DOI:10.3760/cma.j.issn.1007-1245.2024.15.001

乳腺浸润性微乳头状癌的多组学研究进展

Overview of multi-omics research on invasive micropapillary carcinoma in breast

闫晨名 1蔡艺威 1程立浩 1范晓瑞 1贾中明 1王晓红1
扫码查看

作者信息

  • 1. 滨州医学院附属医院乳腺外科,滨州 256603
  • 折叠

摘要

浸润性微乳头状癌是一种罕见的乳腺浸润性癌,由于其发病率较低,且通常与其他组织学类型(如浸润性导管癌)同时存在,极易漏诊.浸润性微乳头状癌具有较高的侵袭能力,严重影响患者的生活质量.随着多组学技术的进步,浸润性微乳头状癌的分子机制得到了进一步阐明,越来越多的潜在靶点已经被揭示.本文旨在综述浸润性微乳头状癌的多组学研究进展.

Abstract

Invasive micropapillary carcinoma is a rare type of invasive carcinoma of the breast that is highly susceptible to missed diagnosis due to its low incidence and its usual coexistence with other histologic types such as invasive ductal carcinoma.Invasive micropapillary carcinoma has high invasive capacity and severely affects the patients'quality of life.With the advancement of multi-omics technology,the molecular mechanism of invasive micropapillary carcinoma has been further elucidated,and more and more potential targets have been revealed.The aim of this article is to review the progress of multi-omics research on invasive micropapillary carcinoma.

关键词

浸润性微乳头状癌/多组学/分子机制/进展

Key words

Invasive micropapillary carcinoma/Multi-omics/Molecular mechanism/Progress

引用本文复制引用

基金项目

国家自然科学基金(81902702)

山东省自然科学基金(ZR2017LH072)

山东省医药卫生科技发展计划(202104010995)

出版年

2024
国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
段落导航相关论文